AstraZeneca's Alexion loses $130M to Syntimmune shareholders in post-merger payment suit
9th September 2024 Uncategorised 0AstraZeneca’s Alexion loses $130M to Syntimmune shareholders in post-merger payment suit zbecker Mon, 09/09/2024 – 11:14 More: AstraZeneca's Alexion loses 0M to Syntimmune shareholders in post-merger payment suit Source: fierce
read more
